Ogasawara S, Oki H, Kaneko M, Hozumi Y, Liu X, Honma R, et al. Development of Monoclonal Antibody LpMab-10 Recognizing Non-glycosylated PLAG1/2 Domain Including Thr34 of Human Podoplanin. Monoclon Antib Immunodiagn Immunother. 2015;34:318-26 pubmed publisher

Chen W, Liu W, Li Y, Luo S, Zhong Y. Preparation and preliminary application of monoclonal antibodies to the receptor binding region of Clostridium difficile toxin B. Mol Med Rep. 2015;12:7712-20 pubmed publisher

Fujii Y, Ogasawara S, Oki H, Liu X, Kaneko M, Takano S, et al. A high-sensitive HMab-2 specifically detects IDH1-R132H, the most common IDH mutation in gliomas. Biochem Biophys Res Commun. 2015;466:733-9 pubmed publisher

Liu J, Du J, Yang Y, Wang Y. Phosphorylation of TRPV1 by cyclin-dependent kinase 5 promotes TRPV1 surface localization, leading to inflammatory thermal hyperalgesia. Exp Neurol. 2015;273:253-62 pubmed publisher

Focà A, Sanguigno L, Focà G, Strizzi L, Iannitti R, Palumbo R, et al. New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding. Int J Mol Sci. 2015;16:21342-62 pubmed publisher

Fujisawa T, Yamaguchi N, Kadowaki H, Tsukamoto Y, Tsuburaya N, Tsubota A, et al. A systematic immunoprecipitation approach reinforces the concept of common conformational alterations in amyotrophic lateral sclerosis-linked SOD1 mutants. Neurobiol Dis. 2015;82:478-486 pubmed publisher

Wang L, Shi W, Joyce M, Modjarrad K, Zhang Y, Leung K, et al. Evaluation of candidate vaccine approaches for MERS-CoV. Nat Commun. 2015;6:7712 pubmed publisher

Thomas S, Fisher K, Snowden J, Danson S, Brown S, Zeidler M. Methotrexate Is a JAK/STAT Pathway Inhibitor. PLoS ONE. 2015;10:e0130078 pubmed publisher

Qin Y, Banerjee S, Agrawal A, Shi H, Banasik M, Lin F, et al. Characterization of a Large Panel of Rabbit Monoclonal Antibodies against HIV-1 gp120 and Isolation of Novel Neutralizing Antibodies against the V3 Loop. PLoS ONE. 2015;10:e0128823 pubmed publisher

Zimmerman S, Michel F, Hogan R, Lafontaine E. The Autotransporter BpaB Contributes to the Virulence of Burkholderia mallei in an Aerosol Model of Infection. PLoS ONE. 2015;10:e0126437 pubmed publisher

Hattori T, Nakashima K, Marutani T, Kiso Y, Nishi Y, Mukai H. Successful acquisition of a neutralizing monoclonal antibody against a novel neutrophil-activating peptide, mitocryptide-1. Biochem Biophys Res Commun. 2015;463:54-9 pubmed publisher

Eksteen M, Tiller H, Averina M, Heide G, KJAER M, Ghevaert C, et al. Characterization of a human platelet antigen-1a-specific monoclonal antibody derived from a B cell from a woman alloimmunized in pregnancy. J Immunol. 2015;194:5751-60 pubmed publisher

Matsumura R, Hirakawa J, Sato K, Ikeda T, Nagai M, Fukuda M, et al. Novel Antibodies Reactive with Sialyl Lewis X in Both Humans and Mice Define Its Critical Role in Leukocyte Trafficking and Contact Hypersensitivity Responses. J Biol Chem. 2015;290:15313-26 pubmed publisher

Ganguly A, Malabadi R, Bhatnagar P, Tang X, Das D, Loebenberg R, et al. Production and characterization of monospecific and bispecific antibodies against dengue virus NS1 protein. J Virol Methods. 2015;220:5-12 pubmed publisher

Liu X, Ogasawara S, Kaneko M, Oki H, Hozumi Y, Goto K, et al. A novel monoclonal antibody SMab-2 recognizes endogenous IDH2-R172S of chondrosarcoma. Biochem Biophys Res Commun. 2015;459:636-42 pubmed publisher

Okamoto M, Iguchi T, Hattori T, Matsuzaki S, Koyama Y, Taniguchi M, et al. DBZ regulates cortical cell positioning and neurite development by sustaining the anterograde transport of Lis1 and DISC1 through control of Ndel1 dual-phosphorylation. J Neurosci. 2015;35:2942-58 pubmed publisher

Ligasová A, Strunin D, Friedecky D, Adam T, Koberna K. A fatal combination: a thymidylate synthase inhibitor with DNA damaging activity. PLoS ONE. 2015;10:e0117459 pubmed publisher

Trinh D, Ogawa H, Bui V, Baatartsogt T, Kizito M, Yamaguchi S, et al. Characterization of mAbs to chicken anemia virus and epitope mapping on its viral protein, VP1. J Gen Virol. 2015;96:1086-97 pubmed publisher

Heng S, Dynon K, Li Y, Edgell T, Walton K, Rombauts L, et al. Development of a high-throughput assay for human proprotein convertase 5/6 for detecting uterine receptivity. Anal Biochem. 2015;475:14-21 pubmed publisher

Nainys J, Lasickiene R, Petraityte Burneikiene R, Dabrisius J, Lelesius R, Sereika V, et al. Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies. BMC Biotechnol. 2014;14:100 pubmed publisher

Yoshimura R, Kyuka A, Jinno M, Nishio S, Matsusaka M, Nishida T, et al. Increase in neuropilin-1 on the surface of growth cones and putative raft domains in neuronal NG108-15 cells co-cultured with vascular smooth muscle SM-3 cells. J Membr Biol. 2015;248:171-8 pubmed publisher

Jiang R, Xu C, Zhou X, Wang T, Yao G. Detection of cystatin C biomarker for clinical measurement of renal disease by developed ELISA diagnostic kits. J Transl Med. 2014;12:205 pubmed publisher

Paek S, Park J, Kim D, Kim H, Ha U, Seo S, et al. Semi-continuous, label-free immunosensing approach for Ca2+-based conformation change of a calcium-binding protein. Analyst. 2014;139:3781-9 pubmed publisher

Westerhout J, van den Berg D, Hartman R, Danhof M, de Lange E. Prediction of methotrexate CNS distribution in different species - influence of disease conditions. Eur J Pharm Sci. 2014;57:11-24 pubmed publisher

Dekaminaviciute D, Kairys V, Zilnyte M, Petrikaite V, Jogaitė V, Matuliene J, et al. Monoclonal antibodies raised against 167-180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity. J Enzyme Inhib Med Chem. 2014;29:804-10 pubmed publisher

Lu Y, Wollak K, Cross V, Westrick E, Wheeler L, Stinnette T, et al. Folate receptor-targeted aminopterin therapy is highly effective and specific in experimental models of autoimmune uveitis and autoimmune encephalomyelitis. Clin Immunol. 2014;150:64-77 pubmed publisher

Venning F, Trempenau M, Schmidt E, Claesson M. Enteroantigen (eAg)-binding B lymphocytes in the mouse - phenotype, distribution, function and eAg-specific antibody secretion. APMIS. 2014;122:616-27 pubmed publisher

Visentin M, Unal E, Zhao R, Goldman I. The membrane transport and polyglutamation of pralatrexate: a new-generation dihydrofolate reductase inhibitor. Cancer Chemother Pharmacol. 2013;72:597-606 pubmed publisher

Dornfeld K. Antifolate response in replication arrest mutants of Saccharomyces cerevisiae. Anticancer Res. 2013;33:2037-41 pubmed

Bigda J, Koszałka P. Wacław Szybalski's contribution to immunotherapy: HGPRT mutation & HAT selection as first steps to gene therapy and hybrid techniques in mammalian cells. Gene. 2013;525:158-61 pubmed publisher

Shimanovsky A, Dasanu C. Pralatrexate : evaluation of clinical efficacy and toxicity in T-cell lymphoma. Expert Opin Pharmacother. 2013;14:515-23 pubmed publisher

Parker T, Barbarotta L, Foss F. Pralatrexate: treatment of T-cell non-Hodgkin's lymphoma. Future Oncol. 2013;9:21-9 pubmed publisher

Teramachi J, Kukita A, Qu P, Wada N, Li Y, Nakamura S, et al. Adenosine blocks aminopterin-induced suppression of osteoclast differentiation. J Bone Miner Metab. 2013;31:64-70 pubmed publisher

Bertino J, Lubin M, Johnson Farley N, Chan W, Goodell L, Bhagavathi S. Lack of expression of MTAP in uncommon T-cell lymphomas. Clin Lymphoma Myeloma Leuk. 2012;12:306-9 pubmed publisher

Abramovits W, Oquendo M, Granowski P, Gupta A, Cather J. Pralatrexate (Folotyn). Skinmed. 2012;10:244-6 pubmed

Schmidt C. Cutaneous T-cell lymphoma's confounding nature. J Natl Cancer Inst. 2012;104:806-8 pubmed publisher

Menter A, Thrash B, Cherian C, Matherly L, Wang L, Gangjee A, et al. Intestinal transport of aminopterin enantiomers in dogs and humans with psoriasis is stereoselective: evidence for a mechanism involving the proton-coupled folate transporter. J Pharmacol Exp Ther. 2012;342:696-708 pubmed publisher

Mathews C. DNA synthesis as a therapeutic target: the first 65 years. FASEB J. 2012;26:2231-7 pubmed publisher

Zhou S, Tian C, Li C, Guo Y, Wang X, Liu J, et al. Novel synthesis of 8-deaza-5,6,7,8-tetrahydroaminopterin analogues via an aziridine intermediate. Molecules. 2012;17:5604-14 pubmed publisher

Ribatti D. Sidney Farber and the treatment of childhood acute lymphoblastic leukemia with a chemotherapeutic agent. Pediatr Hematol Oncol. 2012;29:299-302 pubmed publisher

Foss F, Horwitz S, Coiffier B, Bartlett N, Popplewell L, Pro B, et al. Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL study. Clin Lymphoma Myeloma Leuk. 2012;12:238-43 pubmed publisher

Kelly K, Azzoli C, Zatloukal P, Albert I, Jiang P, Bodkin D, et al. Randomized phase 2b study of pralatrexate versus erlotinib in patients with stage IIIB/IV non-small-cell lung cancer (NSCLC) after failure of prior platinum-based therapy. J Thorac Oncol. 2012;7:1041-8 pubmed publisher

Costa A, Rodrigues M, Henriques M, Melton D, Cunnah P, Oliveira R, et al. Evaluation of the OSCAR system for the production of monoclonal antibodies by CHO-K1 cells. Int J Pharm. 2012;430:42-6 pubmed publisher

Hyoun S, Obican S, Scialli A. Teratogen update: methotrexate. Birth Defects Res A Clin Mol Teratol. 2012;94:187-207 pubmed publisher

Horwitz S, Kim Y, Foss F, Zain J, Myskowski P, Lechowicz M, et al. Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma. Blood. 2012;119:4115-22 pubmed publisher

Azim H, Awada A. Clinical development of new formulations of cytotoxics in solid tumors. Curr Opin Oncol. 2012;24:325-31 pubmed publisher

Hui J, Przespo E, Elefante A. Pralatrexate: a novel synthetic antifolate for relapsed or refractory peripheral T-cell lymphoma and other potential uses. J Oncol Pharm Pract. 2012;18:275-83 pubmed publisher

Fiehn C. A new weapon against an old target. Arthritis Res Ther. 2011;13:122 pubmed publisher

Azzoli C, Patel J, Krug L, Miller V, James L, Kris M, et al. Pralatrexate with vitamin supplementation in patients with previously treated, advanced non-small cell lung cancer: safety and efficacy in a phase 1 trial. J Thorac Oncol. 2011;6:1915-22 pubmed publisher

Antoniu S. Discontinued drugs 2010: rheumatology, allergy and dermatology, pulmonary. Expert Opin Investig Drugs. 2011;20:1175-87 pubmed publisher

Foss F. Evaluation of the pharmacokinetics, preclinical and clinical efficacy of pralatrexate for the treatment of T-cell lymphoma. Expert Opin Drug Metab Toxicol. 2011;7:1141-52 pubmed publisher

Keystone E, Shirinsky V, Simon L, Pedder S, Hewitt L. Efficacy and safety of CH-1504, a metabolically stable antifolate, in patients with active rheumatoid arthritis: results of a phase II multicenter randomized study. J Rheumatol. 2011;38:1875-83 pubmed publisher

Foss F. Hematology: relapsed and refractory PTCL--into the therapeutic abyss. Nat Rev Clin Oncol. 2011;8:321-2 pubmed publisher

Lu Y, Stinnette T, Westrick E, Klein P, Gehrke M, Cross V, et al. Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate. Arthritis Res Ther. 2011;13:R56 pubmed publisher

Kruhlak N, Choi S, Contrera J, Weaver J, Willard J, Hastings K, et al. Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicol Mech Methods. 2008;18:217-27 pubmed publisher

Yuan J, Johnson R, Huang R, Wichterman J, Jiang H, Hayton K, et al. Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nat Chem Biol. 2009;5:765-71 pubmed publisher

Santana L, González Díaz H, Quezada E, Uriarte E, Yáñez M, Viña D, et al. Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. J Med Chem. 2008;51:6740-51 pubmed publisher

Diamandis P, Wildenhain J, Clarke I, Sacher A, Graham J, Bellows D, et al. Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 2007;3:268-73 pubmed

Gangjee A, Lin X, Kisliuk R, McGuire J. Synthesis of N-{4-[(2,4-diamino-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid and N-{4-[(2-amino-4-oxo-5-methyl-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-6-yl)thio]benzoyl}-L-glutamic acid as dual inhibitors of dihyd. J Med Chem. 2005;48:7215-22 pubmed

Gangjee A, Zeng Y, McGuire J, Kisliuk R. Synthesis of classical, four-carbon bridged 5-substituted furo[2,3-d]pyrimidine and 6-substituted pyrrolo[2,3-d]pyrimidine analogues as antifolates. J Med Chem. 2005;48:5329-36 pubmed

Muto R, Ohashi H. [Fetal aminopterin syndrome]. Ryoikibetsu Shokogun Shirizu. 2001;:676-7 pubmed

Garcia Minaur S, Botella M. Further case of aminopterin syndrome sine aminopterin in a Spanish child. Am J Med Genet. 2000;95:320-4 pubmed

Harada M. [Fetal aminopterin syndrome]. Ryoikibetsu Shokogun Shirizu. 2000;:88-9 pubmed

Del Campo M, Kosaki K, Bennett F, Jones K. Developmental delay in fetal aminopterin/methotrexate syndrome. Teratology. 1999;60:10-2 pubmed

Rosowsky A. PT523 and other aminopterin analogs with a hemiphthaloyl-L-ornithine side chain: exceptionally tight-binding inhibitors of dihydrofolate reductase which are transported by the reduced folate carrier but cannot form polyglutamates. Curr Med Chem. 1999;6:329-52 pubmed

Krajewska Walasek M. Aminopterin Syndrome Sine Aminopterin (ASSA) syndrome in two siblings: further delineation of the syndrome and review of the literature. Genet Couns. 1994;5:345-55 pubmed

Palmer D, Skotnicki J, Taylor E. Synthesis of analogues of folic acid, aminopterin and methotrexate as antitumour agents. Prog Med Chem. 1988;25:85-231 pubmed